Category: Uncategorized
-
Welcome Message President of 2026 ACTO Annual Meeting
Distinguished colleagues, esteemed guests, and partners across Asia and beyond, It is an honour and privilege to welcome you to the 17th Annual Meeting of the Asian Cellular Therapy Organization (ACTO), taking place in Jakarta, Indonesia, on August 26–28, 2026. This year marks a pivotal moment for our region as we work collectively to accelerate…
-
Welcome New ACTO Vice President Taipei
Dr. Wannhsin Chen Dr. Wannhsin Chen is a distinguished scientist and leader in stem cell research and regenerative medicine, with more than 30 years of experience spanning fundamental stem cell biology, translational research, therapeutic product development, and regulatory advancement. She currently serves as President of the Taiwan Association for Cellular Therapy (TACT) and Vice President…
-
Welcome New Advisory Board Member
Prof. Kenneth Kaushansky MD, MACP “It is my great honor to join the Board of the Asian Cellular Therapy Organization. It has been a pleasure to have watched the organization grow from its first meeting in 2010 in Japan to its current roster of over a dozen countries and regions. I am particularly impressed with…
-
Before and after “The Stone Age”: Taiwan dual regenerative medicine acts
2018 “Special Regulation” (特管辦法): Establishing a “controlled opening” clinical framework through subordinate regulations, and gradually moving toward dedicated legislation Thai-Yen Ling, Ph.D.Associate Professor, Department and Graduate Institute of PharmacologyCollege of Medicine, National Taiwan University, Taipei, Taiwan Taiwan’s dual regenerative medicine laws were officially implemented on January 1, 2026. Looking back at Taiwan’s legislative journey in…
-
The ACTO Times Website Performance Report
Vijetha Karen Kitchley, M.Sc.International PhD Program in Cell Therapy and Regenerative MedicineTaipei Medical University Over the past three years, the ACTO Times website has demonstrated steady visibility and international reach, with a notable peak in engagement during 2025. Overall Traffic Between January 2024 and February 2026, the website recorded 2.6K total views and 1.1K visitors,…
-
Greeting from Editor-in Chief
THE ACTO TIMES: 2026 New Year EDITION Dear readers and friends of The ACTO Times, As we welcome the New Year 2026, I would like to extend my warmest greetings and sincere appreciation to everyone who has supported The ACTO Times. Your continued engagement through reading, submitting manuscripts, reviewing, and sharing our work has been…
-
Greetings from the ACTO chairperson
The ACTO times: 2026 New Year edition Akihiro Shimosaka Dear ACTO Members and Supporters, We are pleased to distribute the Volume 3 Issue 1 of The ACTO Times 2026 New Year Edition. Thank you for your continuous support of the journal as well as the overall activities of ACTO. ACTO annual meetings have already been held…
-
17th Annual ACTO Meeting
Welcome to the 17th Annual Meeting of the Asian Cellular Therapy Organization (ACTO), organized in collaboration with the Indonesian Stem Cell Association (ASPI). Since its establishment, the ACTO Annual Meeting has served as a premier scientific platform advancing cellular therapy and regenerative medicine across Asia. Over the years, the meeting has been successfully hosted in…
-
Gwo Xi’s stem cell product GXNPC1® shows safety and beneficial effect for stroke patients
Zhi Yong Chong, Chu Lin Tsai, Po Cheng Lin, Ming Hsi Chuang 1Gwo Xi Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan, ROC *Corresponding author: genecold@gwoxi.com GXNPC1®, a novel autologous adipose-derived stem cell therapy for treating chronic stroke, focusing on angiogenesis, neural differentiation, and motor function improvement. ABSTRACT Gwo Xi Stem Cell Applied Technology Co.,…
-
Overview and Recommendations on Taiwan’s Exosome Market: EVs/exosome Definitions, Analytical Methods, and Application Scope
Youlin Wu 1,2 & Chih-hung Huang 11. Institute of Chemical Engineering, National Taipei University of Technology, Taipei, Taiwan.2. Prosperity Bio Co., Ltd., Taipei, Taiwan Introduction: Exosomes as an Emerging Hotspot with Market Chaos Since the 1990s, extracellular vesicles (EVs) were discovered to play immunological roles and to potentially mediate intercellular communication, which sparked a surge…
THE ACTO TIMES 